Synonym: 5-Acetamido-1,3,4-thiadiazole-2-sulfonamide; N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide; N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide
CAS Number: 59-66-5
Empirical Formula (Hill Notation): C4H6N4O3S2
Molecular Weight: 222.25
MDL Number: MFCD00003105
Linear Formula: C4H6N4O3S2
Product Type: Chemical
| API family |
acetazolamide |
| application(s) |
pharmaceutical (small molecule) |
| format |
neat |
| grade |
pharmaceutical primary standard |
| InChI |
1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9) |
| InChI key |
BZKPWHYZMXOIDC-UHFFFAOYSA-N |
| manufacturer/tradename |
USP |
| SMILES string |
CC(=O)Nc1nnc(s1)S(N)(=O)=O |
| Analysis Note: |
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: |
Carbonic anhydrase inhibitor; increases cerebral blood flow. |
| Biochem/physiol Actions: |
Inhibits water permeability of membranes by interacting with aquaporins |
| General description: |
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: |
Sales restrictions may apply. |
GHS07